Fish Oil Quality: How to Choose a Product That Isn't Rancid

← Back to articles

Fish oil is one of the world's most widely consumed supplements — and one whose quality is hardest to judge from the label. Independent surveys of retail products in several countries have found that a meaningful share fail at least one voluntary oxidation benchmark, and that the listed EPA and DHA content is often optimistic. The picture is not uniformly bleak — a very large industry dataset suggests most products on the market do meet the standards — but the variation between products is wide, and a rancid capsule is something you usually cannot smell through the softgel. Oxidized fish oil is unpleasant, may blunt the benefit you are paying for, and at high levels of oxidation is a plausible (though not proven) source of harm. This is a practical buyer's guide to avoiding the bad end of that range.

What "oxidation" actually means

Omega-3 fatty acids such as EPA and DHA are highly unsaturated; the same double bonds that make them biologically active also make them chemically fragile. Heat, light, oxygen and time drive lipid peroxidation, which is tracked with three lab measures: peroxide value (PV), which captures early "primary" oxidation products; p-anisidine value (AnV or pAV), which captures later "secondary" breakdown products such as aldehydes; and the combined TOTOX score (calculated as 2×PV + AnV), a single number meant to reflect both. The industry's Global Organization for EPA and DHA Omega-3s (GOED) publishes voluntary limits widely used as a reference: PV ≤ 5 meq/kg, AnV ≤ 20, and TOTOX ≤ 26. These are voluntary, not legal requirements, and a product can pass one index while failing another.

What the surveys found — and how they disagree

The most-cited alarming study is Albert and colleagues' 2015 analysis of every encapsulated fish oil sold in New Zealand. Of 32 products, only 3 contained as much EPA and DHA as the label claimed (most had under two-thirds), and the large majority exceeded recommended oxidation markers: 83% over the PV limit, 25% over AnV, and 50% over TOTOX, with only 8% clearing all three. Tellingly, best-before date, price and country of origin did not predict quality. A counterweight comes from a 2018 analysis by De Boer and colleagues of more than 1,900 globally sourced fish-oil samples from a third-party testing database, which concluded that retail products "predominantly meet regulatory guidelines" and were comparable in oxidative status to other dietary oils — only about 9% exceeded TOTOX limits. That study, however, included authors affiliated with GOED and a major omega-3 manufacturer, so its favourable framing should be read with the conflict of interest in mind. The honest synthesis: most products are probably acceptable, a non-trivial minority are not, and you cannot tell which is which from marketing claims.

Does oxidized fish oil still work?

This is where it pays to be precise rather than alarmist. Reviews of the clinical literature have not established that consuming moderately oxidized fish oil clearly harms health or fully negates its effects, and the evidence on whether oxidation changes hard outcomes is limited and mixed. What is clearer is the regulatory and quality gap: dietary supplements are not held to the safety-and-efficacy standard of prescription omega-3 products, EPA/DHA content varies widely between and even within brands, and supplements can carry oxidized fatty acids and other unwanted components that prescription formulations are tested to exclude. So the case for choosing a fresh, well-made product is less "rancid oil will hurt you" and more "you should get the dose and quality you paid for."

A note on chemical form

Fish oil is sold in several chemical forms: natural triglyceride (TG), re-esterified triglyceride (rTG), and ethyl ester (EE), the last being a concentrated, lower-cost form produced during processing. Marketing often claims dramatic absorption advantages for TG/rTG over EE. A systematic review of the bioavailability literature found that the EE form does appear to be absorbed somewhat less efficiently than triglyceride and free-fatty-acid forms, but it also concluded that the underlying studies are highly heterogeneous and methodologically weak, so confident, precise multipliers ("X% better") are not well justified. The practical takeaway is modest: a TG/rTG product is a reasonable preference, especially if taken without a fatty meal, but EE fish oil still delivers EPA and DHA, and form matters less than dose, freshness and taking it with food.

How to choose a better product

Look for genuine third-party testing. Certifications such as IFOS (International Fish Oil Standards), USP, or NSF test for oxidation, potency and contaminants; an actual batch certificate (with PV, AnV and TOTOX numbers) is more meaningful than a generic "purity tested" badge. Read the Supplement Facts panel, not the front. A capsule marketed as "1,000 mg fish oil" may contain only 300 mg of combined EPA+DHA; judge a product by its EPA+DHA, and for general use most evidence-based targets fall in the range of roughly 250–1,000 mg/day unless a clinician has advised more. Use freshness cues. Buy from high-turnover retailers, check the expiry date, and do a smell/taste test — truly rancid oil tastes sharply fishy, sour or "paint-like." Store it well. Heat, light and air accelerate oxidation, so keep fish oil cool and dark (refrigeration is reasonable once opened) and finish a bottle within a couple of months rather than letting it linger. Adding an antioxidant such as vitamin E, and choosing liquids or capsules in opaque packaging, also helps slow the process.

Sources

1. Albert BB, Derraik JGB, Cameron-Smith D, et al. "Fish oil supplements in New Zealand are highly oxidised and do not meet label content of n-3 PUFA." Scientific Reports, 2015;5:7928. PMID 25604397.
2. De Boer AA, Ismail A, Marshall K, et al. "Examination of marine and vegetable oil oxidation data from a multi-year, third-party database." Food Chemistry, 2018;254:249–255 (authors affiliated with GOED and an omega-3 manufacturer). PMID 29548449.
3. Fialkow J. "Omega-3 fatty acid formulations in cardiovascular disease: dietary supplements are not substitutes for prescription products." American Journal of Cardiovascular Drugs, 2016;16(4):229–239. PMID 27138439.
4. Ghasemifard S, Turchini GM, Sinclair AJ. "Omega-3 long chain fatty acid 'bioavailability': a review of evidence and methodological considerations." Progress in Lipid Research, 2014;56:92–108. PMID 25218856.
5. Dyerberg J, Madsen P, Møller JM, et al. "Bioavailability of marine n-3 fatty acid formulations." Prostaglandins, Leukotrienes and Essential Fatty Acids, 2010;83(3):137–141. PMID 20638827.